1. Home
  2. RBKB vs SGMO Comparison

RBKB vs SGMO Comparison

Compare RBKB & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RBKB

Rhinebeck Bancorp Inc.

N/A

Current Price

$10.86

Market Cap

139.1M

Sector

Finance

ML Signal

N/A

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.44

Market Cap

155.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBKB
SGMO
Founded
1860
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.1M
155.1M
IPO Year
2019
2000

Fundamental Metrics

Financial Performance
Metric
RBKB
SGMO
Price
$10.86
$0.44
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$4.71
AVG Volume (30 Days)
7.3K
9.3M
Earning Date
10-28-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.46
N/A
Revenue
$45,306,000.00
$32,875,000.00
Revenue This Year
N/A
$28.47
Revenue Next Year
N/A
N/A
P/E Ratio
$24.17
N/A
Revenue Growth
54.93
N/A
52 Week Low
$9.31
$0.38
52 Week High
$13.99
$2.84

Technical Indicators

Market Signals
Indicator
RBKB
SGMO
Relative Strength Index (RSI) 61.03 42.73
Support Level $10.32 $0.38
Resistance Level $11.12 $0.48
Average True Range (ATR) 0.30 0.05
MACD 0.19 0.01
Stochastic Oscillator 83.85 34.75

Price Performance

Historical Comparison
RBKB
SGMO

About RBKB Rhinebeck Bancorp Inc.

Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank which provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management (RAM). The Bank's primary business activity is accepting deposits from the general public and using those funds to originate indirect automobile loans (automobile loans referred by automobile dealerships), commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and one-to four-family residential real estate loans, and to purchase investment securities.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: